Nightstar Therapeutics
London
About Nightstar Therapeutics
NightstaRx Ltd. is a U.K. startup company. Gene therapy is the use of a gene to treat disease. The approach could enable treatments for a several rare conditions caused by mutations in a single gene.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $99.8M
- Funding stage: M&A
- Last round: Series C (Jun 2017)
- Ticker: nasdaq:NITE
- Website: nightstartx.com
- Phone: +442076112077
Industries & Categories
Biotechnology, Genetics, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/nightstar-therapeutics-2211995 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.